Regulation .11 Hepatitis, Viral Type B.
Regulation .11 Hepatitis, Viral Type B.LinkCopy Citation
A.
Control of a Case. A physician in attendance upon a case having viral hepatitis type B shall educate that case on the:
(1)
Risks of sexual transmission, household contact transmission, maternal-infant transmission, and transmission by the sharing of hypodermic needles and other drug paraphernalia;
(2)
Availability of hepatitis B vaccine and hepatitis B immune globulin for contacts who have had sexual contact with a case of hepatitis B within the preceding 14 days, contacts who have percutaneous exposures to hepatitis B, and infants born to case mothers who carry hepatitis B virus at delivery, and the need for referring those contacts to health care providers for preventive treatment;
(3)
Importance of vaccination for viral hepatitis type A if the case is not already immune by reason of prior infection or prior vaccination; and
(4)
Importance of testing pregnant women for hepatitis B surface antigen at each pregnancy.
B.
Control of Contacts. A physician or health officer in attendance upon a contact of viral hepatitis type B shall:
(1)
Educate that contact about the availability of vaccine and hepatitis B immune globulin for contacts with exposure to the case’s blood or other infectious body fluids;
(2)
Recommend preventive treatment consistent with current Centers for Disease Control and Prevention guidelines based on type of exposure; and
(3)
Require that infants born to hepatitis B surface antigen positive mothers:
(a)
Receive hepatitis B immune globulin and the first dose of hepatitis B vaccine within 12 hours of birth;
(b)
Receive the rest of the vaccination series; and
(c)
Are tested for hepatitis B surface antigen and hepatitis B surface antibody at 9 to 15 months old.
C.
Infection Control. Health care providers shall practice standard precautions.